Orchestra BioMed Holdings, Inc. financial data

Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Union Square Drive, New Hope, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Health Sciences Acquisitions Corp 2 (to 1/26/2023)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 594 % -22.1%
Quick Ratio 0.81 %
Debt-to-equity 66.2 %
Return On Equity -89.3 % -57.3%
Return On Assets -60.6 % -50.3%
Operating Margin -2.8K % -174%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.8M shares +5.82%
Common Stock, Shares, Outstanding 35.8M shares +0.23%
Entity Public Float 123M USD -22.7%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.8M shares +3.43%
Weighted Average Number of Shares Outstanding, Diluted 35.8M shares +3.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.08M USD -52.2%
Cost of Revenue 166K USD -19.8%
Research and Development Expense 37.3M USD +23.6%
General and Administrative Expense 2.96M USD +977%
Costs and Expenses 60.4M USD +23.9%
Operating Income (Loss) -58.3M USD -31.3%
Net Income (Loss) Attributable to Parent -55.6M USD -29.2%
Earnings Per Share, Basic -1.56 USD/shares +2.5%
Earnings Per Share, Diluted -1.56 USD/shares +2.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.7M USD +44.5%
Marketable Securities, Current 41.5M USD -59.1%
Accounts Receivable, after Allowance for Credit Loss, Current 80K USD -53.2%
Inventory, Net 70K USD -60.7%
Assets, Current 66.5M USD -44.4%
Property, Plant and Equipment, Net 1.24M USD -12.2%
Operating Lease, Right-of-Use Asset 1.33M USD -29%
Assets 72.4M USD -42.5%
Accounts Payable, Current 6.27M USD +108%
Employee-related Liabilities, Current 1.77M USD -9.31%
Accrued Liabilities, Current 4.23M USD +10.4%
Liabilities, Current 14.5M USD +22.3%
Deferred Income Tax Liabilities, Net 508K USD -20.3%
Operating Lease, Liability, Noncurrent 1.1M USD -15.9%
Other Liabilities, Noncurrent 266K USD
Liabilities 28.3M USD -22.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23K USD +76%
Retained Earnings (Accumulated Deficit) -278M USD -25%
Stockholders' Equity Attributable to Parent 99.8M USD +127788%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 44.1M USD -50.7%
Liabilities and Equity 72.4M USD -42.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +8.81%
Net Cash Provided by (Used in) Financing Activities 56.8M USD +129%
Net Cash Provided by (Used in) Investing Activities 5.86M USD
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 35.8M shares +0.23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.24M USD -564%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.7M USD +44.5%
Deferred Tax Assets, Valuation Allowance 60.1M USD +29.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.5 pure
Deferred Tax Assets, Gross 60.6M USD +28.8%
Operating Lease, Liability 1.45M USD -28.8%
Depreciation 292K USD +8.96%
Payments to Acquire Property, Plant, and Equipment 8K USD -77.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.5M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid 1.74M USD -23.9%
Property, Plant and Equipment, Gross 2.38M USD +2.19%
Operating Lease, Liability, Current 350K USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Two 464K USD +31.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 339K USD -53.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 287K USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 476K USD +35.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 159K USD -54.8%
Operating Lease, Payments 228K USD +11.2%
Additional Paid in Capital 322M USD +3.26%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 74K USD +4.23%
Deferred Tax Assets, Net of Valuation Allowance 508K USD -20.3%
Operating Leases, Future Minimum Payments Due 2.49M USD
Interest Expense 351K USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%